Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Gabrielle Minor

Physician Assistant, Medical Altoona, PA Physician Assistant

NPI 1265815237 CMS profile 10902766

2525 9Th Ave, Altoona, PA 16602

Open in the dashboard

General payments

$10,515

616 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gabrielle Minor of Altoona, PA is reported in the CMS Open Payments database as having received $10,515 across 616 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,052 174
2024 General $2,768 145
2023 General $2,283 133
2022 General $1,620 99
2021 General $792 65

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gabrielle Minor
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Gabrielle Minor were reported at $3,052. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Gabrielle Minor Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $792 $156 $41–$563 $132
2022 $1,620 $185 $55–$649 $149
2023 $2,283 $199 $58–$717 $160
2024 $2,768 $206 $62–$740 $164
2025 $3,052 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $2,013 153 payments
  2. Janssen Biotech, Inc. $1,602 77 payments
  3. Amgen Inc. $771 39 payments
  4. Genzyme Corporation $666 28 payments
  5. E.R. Squibb & Sons, L.L.C. $662 49 payments
  6. Novartis Pharmaceuticals Corporation $616 31 payments
  7. UCB, Inc. $606 31 payments
  8. Regeneron Healthcare Solutions, Inc. $513 19 payments
  9. Sun Pharmaceutical Industries Inc. $478 32 payments
  10. Incyte Corporation $366 15 payments
  11. Other $2,223 142 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $10,135 612 payments
  2. Education $380 4 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $1,430 69 payments
  2. RINVOQ $1,018 64 payments
  3. DUPIXENT Immunology $803 34 payments
  4. Otezla $747 38 payments
  5. SKYRIZI $671 57 payments
  6. SOTYKTU $600 45 payments
  7. COSENTYX $424 22 payments
  8. Bimzelx $409 21 payments
  9. VTAMA $376 25 payments
  10. DUPIXENT Inflammation And Immunology $295 13 payments
  11. Other $4,909 292 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

616 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record